Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,263 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants

NCT05896761

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Fort Lauderdale, Florida, United States
  • GSK Investigational Site Ft. Pierce, Florida, United States
  • GSK Investigational Site Sarasota, Florida, United States
View all 32 locations
View Trial Details
Completed

A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected Children

NCT05197075

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Emory University Atlanta, Georgia, United States
  • Rahima Moosa Mother and Child Hospital, University of Witwatersrand Johannesburg, South Africa
  • Global Clinical Trials PE Pretoria, South Africa
  • Hosp. Gral. Univ. Gregorio Maranon Madrid, Spain
View Trial Details
Completed

Anti-HIV Medications for People Recently Infected With HIV

NCT00106171

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of British Columbia Vancouver, British Columbia, Canada
  • Sunnybrook Health Sciences Ctr. Toronto, Ontario, Canada
  • Canadian Immunodeficiency Research Collaborative (CIRC) Inc. Toronto, Ontario, Canada
View Trial Details

Related conditions